REVIEW ARTICLE: A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older

Autor: STEENS, A., VESTRHEIM, D. F., AABERGE, I. S., WIKLUND, B. S., STORSAETER, J., BERGSAKER, M. A. RIISE, RØNNING, K., FURUSETH, E.

Publikováno v: Epidemiology and Infection, 2014 Dec 01. 142(12), 2471-2482.

Externí odkaz: https://www.jstor.org/stable/24477228

Long-term follow-up of the effectiveness of one whole-cell and two acellular pertussis vaccines based on a randomised controlled vaccine trial in Sweden.

Autor: Aronsson B; The Public Health Agency of Sweden, Solna, Sweden., Appelqvist E; The Public Health Agency of Sweden, Solna, Sweden., Jämtberg K; The Public Health Agency of Sweden, Solna, Sweden., Källberg H; The Public Health Agency of Sweden, Solna, Sweden., Olin P; The Public Health Agency of Sweden, Solna, Sweden., Storsaeter J; The Public Health Agency of Sweden, Solna, Sweden.

Publikováno v: Acta paediatrica (Oslo, Norway : 1992) [Acta Paediatr] 2022 May; Vol. 111 (5), pp. 1052-1053. Date of Electronic Publication: 2021 Dec 10.

COVID-19 vaccines and anaphylaxis-evaluation with skin prick testing, basophil activation test and Immunoglobulin E.

Autor: Csuth À; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden., Nopp A; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden., Storsaeter J; Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden., Nilsson L; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden., Jenmalm MC; Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Jun; Vol. 52 (6), pp. 812-819. Date of Electronic Publication: 2022 Apr 28.

Waning infant pertussis during COVID-19 pandemic.

Autor: Falkenstein-Hagander K; Public Health Agency of Sweden, Solna, Sweden kathy.falkenstein-hagander@skane.se., Appelqvist E; Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden., Cavefors AF; Central Child Health Services Unit, Gothenburg, Sweden., Källberg H; Public Health Agency of Sweden, Solna, Sweden., Nilsson LJ; Allergy Center, Department of Biomedical and Clinical Sciences, Linkoping University, Linkoping, Sweden., Silfverdal SA; Unit of Pediatrics, Department of Clinical Sciences/Paediatrics, Sven-Arne Silfverdal, Umeå University, Umeå, Sweden., Storsaeter J; Public Health Agency of Sweden, Solna, Sweden., Aronsson B; Public Health Agency of Sweden, Solna, Sweden.

Publikováno v: Archives of disease in childhood [Arch Dis Child] 2022 Mar; Vol. 107 (3), pp. e19. Date of Electronic Publication: 2021 Dec 02.

Vaccine allergy: evidence to consider for COVID-19 vaccines.

Autor: Nilsson L; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping., Csuth Á; Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping., Storsaeter J; Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden., Garvey LH; Allergy Clinic, Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Jenmalm MC; Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Publikováno v: Current opinion in allergy and clinical immunology [Curr Opin Allergy Clin Immunol] 2021 Aug 01; Vol. 21 (4), pp. 401-409.